Reuters logo
BRIEF-Nordic Nanovector to present updated trial results
June 13, 2017 / 5:09 AM / 6 months ago

BRIEF-Nordic Nanovector to present updated trial results

June 13 (Reuters) - Nordic Nanovector Asa

* Will host a conference call on June 14 to present updated results from its ongoing lymrit 37-01 phase 1/2 clinical trial of betalutin in patients with relapsed/refractory indolent non-hodgkin’s lymphoma

* These data will be presented at the International Conference on Malignant Lymphoma (ICML) on 14-17 June in Lugano, Switzerland Source text for Eikon: Further company coverage: (Reporting by Terje Solsvik)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below